Phytochemical Composition, Bioactivities, and Medicinal Value of Salvia nemorosa L.

Abstract

Salvia nemorosa L. (Lamiaceae) is a perennial herb native mainly to Europe and Western Asia and has a fragmented but longstanding record of ethnomedicinal use. Although widely distributed, it remains a relatively underexplored member of the Salvia genus. Recent investigations have revealed that S. nemorosa is a rich source of bioactive secondary metabolites, particularly phenolic acids, flavonoids, diterpenoids, triterpenoids, megastigmane glycosides, and volatile terpenoids. Among these, rosmarinic acid, sagerinic acid, and caffeoylquinic acids are predominant constituents contributing to its pronounced antioxidant and anti-inflammatory activities. Essential oils of S. nemorosa are characterized by high levels of sesquiterpenes, such as β-caryophyllene and caryophyllene oxide, which exhibit notable antimicrobial, cytotoxic, and neuroprotective properties. A critical comparison of published data indicates pronounced quantitative and qualitative variability related to geographical origin, plant organ, developmental stage, cultivation conditions, and extraction/analytical procedures. Comparative studies with other Salvia species suggest that S. nemorosa can show high antioxidant or enzyme-inhibitory activity under particular experimental conditions, but these findings are not consistent across all assays or populations. Evidence for the biological activity of S. nemorosa itself is predominantly derived from in vitro experiments, while in vivo and clinical evidence remains lacking or very limited. Earlier isolation studies also demonstrate that the phytochemistry of the species extends beyond common phenolic compounds and volatile constituents, including quinones, diterpenoids, triterpenoids, and megastigmane glycosides. This review critically synthesizes the available evidence, with emphasis on phytochemical variability, plant-organ and geographical differences, comparisons with other Salvia species, and the limitations that currently prevent firm conclusions regarding therapeutic applications.